Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Mark Brantly, MD, scientific director of the Alpha-1 Foundation, ahead of the organization’s August 28, 2021, “Virtual Education Day.” Dr. Brantly is the vice-chair of research in the Department of Medicine at the University of Florida in Gainesville, and has spent most of his career researching a cure for alpha-1 antitrypsin deficiency (AATD).
Read the full article: Emerging Therapies, COVID-19 Highlight Alpha-1 Foundation’s Upcoming ‘Virtual Education Day’
